ACSG
American Century Small Cap Growth Insights ETF
American Century Small Cap Growth Insights ETF seeks to provide long-term capital appreciation by investing primarily in small-cap growth companies with strong growth potential.
US
EQUITY
Active
MANAGEMENT STYLE
$ 53.8 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Oct 14, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| REGAL BELOIT CORP | 1.6 % |
| CRANE HOLDINGS, CO. | 1.0 % |
| KRYSTAL BIOTECH, INC. | 0.9 % |
| WEATHERFORD INTERNATIONAL PL | 0.9 % |
| EXPRO LTD | 0.8 % |
| AGILYSYS INC | 0.8 % |
| HERC HOLDINGS, INC. | 0.8 % |
| RADNET INC | 0.8 % |
| 10X GENOMICS INC CLASS A | 0.8 % |
| LIFE TIME GROUP HOLDINGS INC | 0.8 % |
Constituent Breakdown
| Number of holdings | 306 |
| Herfindahl-Hirschman Index | 8 |
| Wgt avg mkt cap (mns) | $5,147 |
| Large cap (>$10bn) | 12.1% |
| Mid cap ($2-10bn) | 69.1% |
| Small cap (<$2bn) | 9.0% |
| Developed mkts. | 29.5% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 87.0 % |
 |
CANADA | 2.2 % |
 |
SWITZERLAND | 1.0 % |
 |
IRELAND | 0.5 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.7% | -- | -- | -- | -- | -- | -- | 14.0% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | 12.7% | -- | -- | -- | -- | -- | -- | 14.0% | Ann. Volatility | 21.7% | -- | -- | -- | -- | -- | -- | 21.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.78 | 75% |
| MSCI EAFE | 0.83 | 89% |
| MSCI Emg Mkts | 0.73 | 82% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.16% |
Technical Indicators
| 30d moving avg. (EMA) | $46.10 |
| Relative strength (RSI) | 47 |
| MACD/Signal | -0.20/-0.41 |
| Bollinger Bands (Upper/Lower) | $47.20/$44.17 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ACSG |
Expenses vs. ACSG |
ALTAR Score™ vs. ACSG |
|---|---|---|---|---|
| VTWG | Vanguard Russell 2000 Growth ETF | 37.4% | -43 bp | -0.4% |
| IWO | iShares Russell 2000 Growth ETF | 37.0% | -25 bp | -0.6% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 28.2% | +24 bp | +1.6% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 27.4% | -34 bp | +3.7% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 27.1% | -31 bp | +3.6% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 26.7% | -40 bp | +3.5% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 26.3% | -43 bp | +2.4% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 26.2% | -39 bp | +3.8% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 25.7% | +46 bp | -0.1% |
| RSSL | Global X Russell 2000 ETF | 25.5% | -41 bp | +2.1% |
Risk and Returns: ACSG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.9%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,395 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. ACSG's ALTAR Score™ is approximately -2.2 standard
deviations above the category average. This places ACSG in the 1st percentile
among funds in the category.
Sell-Side Consensus
$59.33
PRICE TARGET
+30.8%
UPSIDE